SEC Comment Letter for BIOMERICA INC (BMRA) (CIK 0000073290) (BMRA) — Sep 29, 2023
BIOMERICA INC (BMRA) (CIK 0000073290)
Date: Sept. 29, 2023 · CIK: 0000073290 · Accession: 0000000000-23-010840
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-274729
Letter
United States securities and exchange commission logo September 29, 2023 Zackary Irani Chairman & Chief Executive Officer Biomerica, Inc. 17571 Von Karman Avenue Irvine, California 92614 Re:Biomerica, Inc. Registration Statement on Form S-3 Filed September 28, 2023 File No. 333-274729 Dear Zackary Irani: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Christopher D. Ivey, Esq.
Show Raw Text
United States securities and exchange commission logo
September 29, 2023
Zackary Irani
Chairman & Chief Executive Officer
Biomerica, Inc.
17571 Von Karman Avenue
Irvine, California 92614
Re:Biomerica, Inc.
Registration Statement on Form S-3
Filed September 28, 2023
File No. 333-274729
Dear Zackary Irani:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Christopher D. Ivey, Esq.